» Articles » PMID: 24643215

Use of Treatment Information from a State Central Cancer Registry in Prostate Cancer Research

Overview
Specialty Oncology
Date 2014 Mar 20
PMID 24643215
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

A method was developed to categorize prostate cancer treatments for epidemiologic and outcomes studies. A total of 60,497 prostate cancer cases from the Florida Cancer Data System diagnosed between 2001 and 2007 were used. The classification has the following properties. First, the treatments classified in the same group are clinically comparable and capture all prostate cancer treatments or combinations of treatments (exhaustive classification). Second, the grouping was set up in a way that each patient is captured in only 1 treatment category without leaving out any patient due to treatment type (mutually exclusive categories). The prostate cancer cases were initially categorized into 14 combinations of treatment, which were then collapsed into 8 broader groups in order to maintain a large sample size for all groups, with treatments remaining clinically comparable within a group.

Citing Articles

Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.

Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Gwede C Am J Mens Health. 2013; 8(4):316-26.

PMID: 24297455 PMC: 4040343. DOI: 10.1177/1557988313512862.

References
1.
Malin J, Kahn K, Adams J, Kwan L, Laouri M, Ganz P . Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002; 94(11):835-44. DOI: 10.1093/jnci/94.11.835. View

2.
Cooperberg M, Carroll P, Klotz L . Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011; 29(27):3669-76. DOI: 10.1200/JCO.2011.34.9738. View

3.
Fowler Jr F, McNaughton Collins M, Albertsen P, Zietman A, Elliott D, Barry M . Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000; 283(24):3217-22. DOI: 10.1001/jama.283.24.3217. View

4.
Kibel A, Ciezki J, Klein E, Reddy C, Lubahn J, Haslag-Minoff J . Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol. 2012; 187(4):1259-65. DOI: 10.1016/j.juro.2011.11.084. View

5.
Parkin D . The evolution of the population-based cancer registry. Nat Rev Cancer. 2006; 6(8):603-12. DOI: 10.1038/nrc1948. View